Latest Articles
UNM physician gets $12.9M grant to study endometrial cancer - KOB.com
UNM physician gets $12.9M grant to study endometrial cancer KOB.com
Published: Sept. 24, 2025, 5:39 p.m.
UNM Cancer Center Physician-Scientist Awarded $12.9M Grant to Study Endometrial Cancer | Newswise - Newswise
UNM Cancer Center Physician-Scientist Awarded $12.9M Grant to Study Endometrial Cancer | Newswise Newswise
Published: Sept. 24, 2025, 12:05 p.m.
Spotlighting Disease Prevention Efforts Alongside Treatment Breakthroughs Are Crucial for Endometrial Cancer Risk Reduction - OncLive
Spotlighting Disease Prevention Efforts Alongside Treatment Breakthroughs Are Crucial for Endometrial Cancer Risk Reduction OncLive
Published: Sept. 23, 2025, 8:09 p.m.
Ovarian cancer patient says medics dismissed her symptoms - BBC
Ovarian cancer patient says medics dismissed her symptoms BBC
Published: Sept. 23, 2025, 5:05 a.m.
'My tumour grew to 2kg after GPs missed my cancer' - BBC
'My tumour grew to 2kg after GPs missed my cancer' BBC
Published: Sept. 23, 2025, 5:05 a.m.
Sheffield ovarian cancer patient says medics dismissed her symptoms - BBC
Sheffield ovarian cancer patient says medics dismissed her symptoms BBC
Published: Sept. 23, 2025, 5:05 a.m.
Pioneering robotic surgery for complex gynecologic conditions: implementation beyond cancer care.
Minimally invasive surgery was introduced to minimize some of the issues associated with open surgery. Its benefits include fewer complications, less pain and blood loss, shorter hospital stays, quicker recovery, …
Published: Sept. 23, 2025, midnight
Jemperli Scores Korean Coverage Ahead of Keytruda in Endometrial Cancer - NAVLIN DAILY
Jemperli Scores Korean Coverage Ahead of Keytruda in Endometrial Cancer NAVLIN DAILY
Published: Sept. 22, 2025, 11:27 p.m.
Huntsman Cancer Institute Discovery Innovations Fall 2025 | Newswise - Newswise
Huntsman Cancer Institute Discovery Innovations Fall 2025 | Newswise Newswise
Published: Sept. 22, 2025, 11:15 p.m.
95% Success Rate: IceCure's Breakthrough Cryoablation System Proves Effective in Multiple Cancer Studies - Stock Titan
95% Success Rate: IceCure's Breakthrough Cryoablation System Proves Effective in Multiple Cancer Studies Stock Titan
Published: Sept. 22, 2025, 12:30 p.m.
Link copied to clipboard!